Hostname: page-component-6898cfcb55-w5hgh Total loading time: 0 Render date: 2026-11-11T20:33:21.146Z Has data issue: false hasContentIssue false
  • English
  • Français

PMDD: Definition and Prevalence

Published online by Cambridge University Press:  07 November 2014

Teri Pearlstein
Get accessRights & Permissions [Opens in a new window]

Extract

Premenstrual dysphoric disorder (PMDD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) as the presence of at least 5 of 11 symptoms with at least one of the symptoms being depressed mood, anxiety, affective lability, or irritability. The other symptoms include decreased interest in usual activities, poor concentration, fatigue, increased appetite, change in sleep, a sense of being overwhelmed or out of control, and physical symptoms such as breast tenderness. The symptoms must be present in the luteal (premenstrual) phase of the menstrual cycle, must resolve during the first few days of menses, and must have been present for at least 1 year. The symptoms should be severe enough to disrupt social and role functioning. The DSM-IV PMDD criteria include the recommendation that women prospectively rate their symptoms daily for two menstrual cycles to confirm the timing of the symptoms and the absence of a chronic underlying Axis I disorder. Many studies have identified irritability as the most frequently reported premenstrual symptom. It has been proposed that women with PMDD may comprise two subsets; one with predominant depressive symptoms, and another with predominant irritability.

Information

Type
Symposium Monograph Supplement
Information
CNS Spectrums , Volume 9 , Issue 9 , September 2004, pp. 8 - 9
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
2. Landen, M, Eriksson, E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety. 2003;17(3):122–129.CrossRefGoogle ScholarPubMed
3. Halbreich, U, Borenstein, J, Pearlstein, T, Kahn, LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psycboneuroendocrinology. 2003;28(Suppl 3):1–23.Google ScholarPubMed
4. Wittchen, HU, Becker, E, Lieb, R, Krause, P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1): 119–132.CrossRefGoogle ScholarPubMed
5. Yonkers, KA. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?, J Clin Psychiatry. 1997;58(Suppl 3):62–67.Google ScholarPubMed
6. Wittchen, HU, Perkonigg, A, Pfister, H. Trauma and PTSD—an overlooked pathogenic pathway for premenstrual dysphoric disorder? Arch Women Ment Health. 2003;6(4):293–297.CrossRefGoogle Scholar
7. Kovac, SH, Klapow, JC, Kroenke, K, Spitzer, RL, Williams, JB. Differing symptoms of abused versus nonabused women in obstetric-gynecology settings. Am J Obstet Gynecol. 2003;188(3):707–713.CrossRefGoogle ScholarPubMed
8. Girdler, SS, Sherwood, A, Hinderlker, AL, et al. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med. 2003;65(5):849–856.CrossRefGoogle ScholarPubMed
9. Kim, DR, Gyulai, L, Freeman, EW, Morrison, MF, Baldassano, C, Dube, B. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Women Ment Health. 2004;7(1):37–47.CrossRefGoogle ScholarPubMed
10. Hsiao, MC, Hsiao, CC, Liu, CY. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psych Clin Neurosci. 2004;58(2):186–190.CrossRefGoogle ScholarPubMed
11. Howell, HB, Brawman-Mintzer, O, Monnier, J, Yonkers, KA. Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001;24(1):165–178.CrossRefGoogle ScholarPubMed
12. Halbreich, LI. The etiology, biology, and evolving pathology of premenstrual syndromes. Psycboneuroendocrinology. 2003;28(Suppl 3):55–99.CrossRefGoogle ScholarPubMed
13. Shear, MK. Anxiety disorders in women: gender-related modulation of neurobiology and behavior. Sem Reprod Endocrinol. 1997;15(1):69–76.CrossRefGoogle ScholarPubMed
14. Kent, JM, Papp, LA, Martinez, JM, et al. Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am J Psychiatry. 2001;158(1):58–67.CrossRefGoogle ScholarPubMed
15. Dimmock, PW, Wyatt, KM, Jones, PW, O'Brien, PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356(9236):1131–1136.CrossRefGoogle ScholarPubMed
16. Pearlstein, T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs. 2002;62(13):1869–1885.CrossRefGoogle ScholarPubMed
17. Pearlstein, T, Steiner, M. Non-antidepressant treatment of premenstrual syndrome. J Clin Psychiatry. 2000;61(Suppl 12):22–27.Google ScholarPubMed
18. Hunter, MA, Ussher, JM, Cariss, M, Browne, S, Jelley, R, Katz, M. Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes. J Psychosom Res. 2002;53(3):811–817.CrossRefGoogle ScholarPubMed